Standardizing care for acute decompensated heart failure in a large megatrial: The approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF)

American Heart Journal

Volumn 157, Issue 2, 2009, Pages 219-228

  Ezekowitz, Justin A ^a   Hernandez, Adrian F ^b   Starling, Randall C ^c   Yancy, Clyde W ^d   Massie, Barry ^e   Hill, James A ^f   Krum, Henry ^g   Diaz, Rafael ^h   Ponikowski, Piotr ⁱ   Metra, Marco ^j   Howlett, Jonathon G ^k   Gennevois, Daniel ^l   O'Connor, Christopher M ^b   Califf, Robert M ^b   Fonarow, Gregg C ^m  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g MONASH UNIVERSITY   (Australia)

^h Instituto Cardiovascular de Rosario   (Argentina)

ⁱ MILITARY HOSPITAL   (Poland)

^j UNIVERSITY OF BRESCIA   (Italy)

^k DALHOUSIE UNIVERSITY   (Canada)

^l Johnson and Johnson Inc   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CHLOROTHIAZIDE; DIAMORPHINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; ISOSORBIDE DINITRATE; LEVOSIMENDAN; METOLAZONE; METOPROLOL SUCCINATE; MILRINONE; MORPHINE; NESIRITIDE; NITRATE; NITROPRUSSIDE SODIUM; OPIATE; SPIRONOLACTONE; UNINDEXED DRUG; VASODILATOR AGENT;

ACUTE DECOMPENSATED HEART FAILURE; ACUTE HEART FAILURE; CLINICAL TRIAL; CREATININE CLEARANCE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EVIDENCE BASED PRACTICE; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HUMAN; LONG TERM CARE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SODIUM RESTRICTION; STANDARDIZATION; SYMPTOMATOLOGY; ULTRAFILTRATION;

ACUTE DISEASE; CARDIOVASCULAR AGENTS; HEART FAILURE; HUMANS; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PATIENT DISCHARGE;

EID: 58749092123     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.10.002     Document Type: Review

References (43)

1. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
2. Komajda M., Follath F., Swedberg K., et al. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24 (2003) 464-474
3. Nieminen M.S., Brutsaert D., Dickstein K., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 (2006) 2725-2736
4. Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296 (2006) 2217-2226
5. Fonarow G.C., Adams Jr. K.F., Abraham W.T., et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
6. Heart Failure Society of America. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 12 (2006) e1-e2
7. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
8. Arnold J.M., Liu P., Demers C., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 22 (2006) 23-45
9. Nieminen M.S., Böhm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
10. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
11. Allen L.A., and O'Connor C.M. Management of acute decompensated heart failure. CMAJ 176 (2007) 797-805
12. Gheorghiade M., Zannad F., Sopko G., et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958-3968
13. Peacock IV W.F., De Marco T., Fonarow G.C., et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 358 (2008) 2117-2126
14. Peter J.V., Moran J.L., Phillips-Hughes J., et al. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet 367 (2006) 1155-1163
15. Gray A, Goodacre S, Newby DE, et al. Noninvasive ventillation in acute cardiogenic pulmonary edema. N Engl J Med 2008;359:142-51.
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
17. Salvador D.R., Rey N.R., Ramos G.C., et al. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev (2005) CD003178
18. Mehta R.L., Pascual M.T., Soroko S., et al., for the PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288 (2002) 2547-2553
19. The VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287 (2002) 1531-1540
20. Cotter G., Metzkor E., Kaluski E., et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351 (1998) 389-393
21. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
22. Hernandez A.F., O'Connor C.M., Starling R.C., et al. Rationale and design of the acute study of clinical effectiveness of nesiritide in decompensated heart failure (ASCEND-HF). Am Heart J 157 (2008) 271-277
23. Costanzo M.R., Guglin M.E., Saltzberg M.T., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 675-683
24. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006) e247-e346
25. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. Circulation 97 (1998) 2202-2212
26. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353 (1999) 9-13
27. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). JAMA 283 (2000) 1295-1302
28. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group. Lancet 349 (1997) 375-380
29. IMPACT-HF Investigators and Coordinators. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 43 (2004) 1534-1541
30. Butler J., Young J.B., Abraham W.T., et al. Beta-blocker use and outcomes among hospitalized heart failure patients. J Am Coll Cardiol 47 (2006) 2462-2469
31. Metra M., Torp-Pedersen C., Cleland J.G., et al. Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail 9 (2007) 901-909
32. Fonarow G.C., Abraham W.T., Albert N.M., et al. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. J Am Coll Cardiol 52 (2008) 190-199
33. Fuster V., Rydén L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48 (2006) 854-906
34. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 (2008) 381S-453S
35. Smith Jr. S.C., Allen J., Blair S.N., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 47 (2006) 2130-2139
36. Zhang J., Ding E.L., and Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA 296 (2006) 1619-1632
37. Tsuyuki R.T., McKelvie R.S., Arnold J.M., et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med 161 (2001) 2337-2342
38. Ackman M.L., Campbell J.B., Buzak K.A., et al. Use of nonprescription medications by patients with congestive heart failure. Ann Pharmacother 33 (1999) 674-679
39. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
40. Arnold J.M., Howlett J.G., Ducharme A., et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure-2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol 24 (2008) 21-40
41. Ross H., Howlett J., Arnold J.M., et al. Treating the right patient at the right time: access to heart failure care. Can J Cardiol 22 (2006) 749-754
42. Ezekowitz J.A., van Walraven C., McAlister F.A., et al. Impact of specialist follow-up in outpatients with congestive heart failure. CMAJ 172 (2005) 189-194
43. Ezekowitz J.A., Bakal J.A., Kaul P., et al. Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure. Eur J Heart Fail 10 (2008) 308-314